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From November 2nd - 4th 2012, the 4th NEUROWIND e.V. meeting was held in Motzen, Brandenburg, Germany.
Again more than 60 participants, predominantly at the doctoral student or postdoc level, gathered to share their
latest findings in the fields of neurovascular research, neurodegeneration and neuroinflammation. Like in the
previous years, the symposium provided an excellent platform for scientific exchange and the presentation of
innovative projects in the stimulating surroundings of the Brandenburg outback. This year’s keynote lecture on the
pathophysiological relevance of neuronal networks was given by Christian Gerloff, Head of the Department of
Neurology at the University Clinic of Hamburg-Eppendorf. Another highlight of the meeting was the awarding of
the NEUROWIND e.V. prize for young scientists working in the field of experimental neurology. The award is
donated by the Merck Serono GmbH, Darmstadt, Germany and is endowed with 20.000 Euro. This year the jury
decided unanimously to adjudge the award to Michael Gliem from the Department of Neurology at the University
Clinic of Düsseldorf (group of Sebastian Jander), Germany, for his outstanding work on different macrophage
subsets in the pathogenesis of ischemic stroke published in the Annals of Neurology in 2012.Summary of the scientific contributions to the
NEUROWIND e.V. meeting 2012
Contributions on stroke and vascular pathology
Mathias Gelderblom from the group of Tim Magnus,
Hamburg, reported on the role of the IL-17 axis in a
murine model of ischemic stroke. He nicely showed that
gamma delta T cell derived IL-17, TNF-α, and CXCL1
are important mediators of neutrophil invasion and tis-
sue damage after an ischemic insult.
Next, Arthur Liesz from the group of Roland Veltkamp,
Heidelberg, gave a talk on clonal expansion of T cells
after experimental stroke. Via CDR3 spectratyping, he* Correspondence: ralf.linker@uk-erlangen.de; sven.meuth@ukmuenster.de; t.
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reproduction in any medium, provided the orshowed monoclonal and oligoclonal TCR expansion pat-
terns especially in the brain at later time points after
ischemia.
Katarzyna Winek from the group of Andreas Meisel,
Berlin, presented preliminary findings on the link be-
tween gut microbiota and cerebral ischemia and vice
versa. By using deep sequencing of the gut microbiome,
different surgery conditions for ischemia induction and
gut decontamination, it might become possible to unveil
an influence of the microbiome on brain infarction in
the future.
Sweena Chaudhari from Alma Zernecke`s laboratory
in Munich focused on the role of the transcription factor
HIF-1α in dendritic cells (DC). An increased atheroscler-
otic plaque growth was observed in a DC specific condi-
tional HIF-1α knockout mouse on a high fat diet. This
phenotype is associated with increased IL-12 expressiontd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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STAT3.
Golo Kronenberg (group of Matthias Endres, Berlin)
employed transient middle cerebral artery occlusion
(tMCAO) in combination with the Porsolt forced swim test
and citalopram treatment to analyze post-stroke depression
in mice. This model allows for probing monoaminergic
transmitter mediated effects after cerebral ischemia, both
on a behavioral and neurochemical level.
Christoph Harms from Berlin focused on the role of
small ubiquitin-like modifiers (SUMO) in neuroprotection
during stroke. He reported that in an oxygen glucose
deprivation cell culture model, the formation of SUMO2/3
conjugates is part of the cellular stressresponse. This
process may be modulated by RNA interference with
SUMO2/3 itself or sentrin specific isoproteases (SENP) as
deSUMOylating enzymes.
Daniel-Christoph Wagner from Johannes Boltze`s lab
in Leipzig induced photothrombotic brain infarctions in
a humanized mouse model on the basis of the NOD-
SCID-gamma (NSG) mouse. This model may allow for
studying the role of the immune system after stroke in a
setting closer to the human situation.
In a translational talk, Jens Minnerup from Münster
weighed the pros and cons of mononuclear bone-marrow
derived cells as a potential new therapeutic option for the
treatment of ischemic stroke. However, injection of these
cells three hours after the onset of ischemia in a rat
tMCAO model had no effect on the clinical outcome or
immune parameters.
Peter Kraft from Christoph Kleinschnitz`s group in
Würzburg investigated the role of Foxp3 positive regulatory
T cells (Treg) in experimental stroke using DEREG mice.
Surprisingly, a detrimental rather than a beneficial function
of Treg in ischemic stroke was reported which independent
of the immune regulatory function of Treg. Instead, Treg-
endothelium and Treg-platelet interaction may play a key
role in this process thus identifying ischemic stroke as a
“thrombo-inflammatory“ disease.
Alexander Venus from the group of Marc Fatar,
Mannheim, serially investigated APP 23 („Swedish muta-
tion“) transgenic mice by in vivo high-field (9.4T) magnetic
resonance imaging (MRI) to visualize amyloid plaques,
microbleedings and vasculopathy. These investigations may
help to establish the APP 23 model as a suitable tool for
further studies on the pathogenesis of cerebral amyloid
angiopathy.
In a related approach, Stefanie Schreiber from Klaus
Reymann`s group in Magdeburg examined the process
of small vessel disease in spontaneously hypertensive
stroke prone rats (SHSPR). This model is characterized
by lipohyalinosis and microthrombosis including capil-
lary changes as well as a hypercoagulation state already
at an early phase of the disease. Moreover, brainchanges are obviously paralleled by hypertensive
nephropathy.
Contributions on neuroimmunology
Stefanie Kürten, Cologne, gave an interesting overview
on the role of B cells in a mouse model of multiple scler-
osis (MS) induced by the immunization with the MP4
fusion protein. A pathological hallmark of this model is
the formation of B cell aggregates in the CNS, similar to
MS patients. These tertiary lymphatic structures may
play a detrimental role in the pathogenesis of the
disease.
Stefan Bittner from Sven Meuth`s laboratory in Münster
focused on TREK channels in neuroinflammation. The
group found that upon experimental autoimmune enceph-
alomyelitis (EAE) TREK1 channel expression is regulated
at the blood brain barrier and in neurons thus suggesting a
dual role of this molecule in immune cell transmigration
and direct neuroprotection.
Nils Schweingruber from the group of Holger Reichardt
and Fred Lühder, Göttingen, reported on mechanisms of
glucocorticoid action in murine EAE. Using different
glucocorticoid receptor knockout mice, he showed that
altered migration of (naive and memory) T cells rather
than induction of apoptosis is critical for the beneficial
effects of the prototypic glucocorticoid compound dexa-
methasone in a process mediated via CXCR4.
Tobias Goldmann from Freiburg (lab of Marco Prinz)
gave a presentation on the role of ubiquitin specific pro-
tease 18 (USP 18) in type 1 interferon (IFN) signaling.
USP 18 deficient mice suffer from hydrocephalus and
microgliosis with increased expression of proinflamma-
tory cytokines and signs of myelin phagocytosis. Further
studies were performed to delineate a direct functional
interaction of USP 18 with type I IFN receptors.
Christiane Opitz who works in the group of Michael
Platten in Heidelberg investigated the tryptophane
metabolism in malignant gliomas. The group provided
compelling evidence that tryptophane dioxygenase
(TDO) is the main enzyme of tryptophane metabolism
in glioma cells leading to production of kynurenine.
Thus, TDO exerts autocrine effects (on tumor cells) and
paracrine effects (on immune cells) via kynurenine-
mediated activation of the aryl hydrocarbon receptor.
IIn a presentation on autoimmune-mediated synaptic
transmission diseases of the CNS, Christian Geis from Jena
reported on stiff person syndrome with anti-amphiphysin
antibodies. After intrathecal transfer of these auto-
antibodies in rats, there is a GABAergic transmission failure
which can be modeled clinically, electrophysiologically and
histologically. On a molecular basis, the observed changes
may be due to a defect in vesicle endocytosis.
Sina Schröder from the group of Ralf Linker, Erlangen,
gave a presentation on the role of non-classical
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and renal inflammation, classical monocytes are highly
efficient phagocytes while non-classical monocytes may
exert a patrolling function along blood vessels or in
damaged tissue.
Florian Kurschus from Ari Waisman`s group in Mainz
presented data on a novel PI3 kinase pathway in EAE
which involves IL-22 and which is essential for defining
T cell differentiation.
Focusing on vasoactive intestinal peptide (VIP), pituit-
ary adenylate cyclase-activating polypeptide (PACAP),
and the cognate VPAC receptors, Dina Hartmann from
the group of Björn Tackenberg (Marburg) provided
novel data on the neuroendocrine modulation of T cell
responses in MS.
IInessa Schwab from Falk Nimmerjahn`s lab in Erlangen
talked about the cellular and molecular requirements for
the in vivo activity of intravenous immunoglobulin (IVIG)
therapy. She put special emphasis on Fc-mediated effects
and concentrated on the impact of IVIG glycosylation
as well as the role of Fcgamma receptor IIb in animal mod-
els of rheumatoid arthritis and immune thrombocyto-
penia (ITP).I In addition, samples from patients suffering
from chronic inflammatory demyelinating polyneuropathy
(CIDP) treated with IVIG were analyzed.Contributions on neurodegeneration
IThomas Koegelsperger explained the impact of transform-
ing growth factor beta 1 (TGFβ1) on synaptic plasticity and
neuronal function. In a CNS specific TGFβ1 knockout
mouse model there is a mild reduction of neurons and
synapses in the hippocampus, astrogliosis and a defect in
glutamate reuptake. This phenotype is associated with syn-
aptic and extrasynaptic effects in hippocampal neurons
thus highlighting an intricate interplay between the im-
mune system, glial cells and neuronal function.
IMarisa Karow (Munich) highlighted the novel method
of direct reprogramming of CNS cells. Her group suc-
ceeded in generating (mostly GABAergic) neurons from
CD146/Pdgfrβ double positive cells (pericytes) derived from
the adult human brain via retroviral transduction with
SOX2 and Mash1. If developed further, this promising
technology may open novel avenues for the treatment of
various neurological diseases.
The work by Johannes Schlachetzki from the labora-
tory of Jürgen Winkler, Erlangen, addressed the effects
of oxidative stress on the posttranslational modification
of alpha synuclein (PTM-Syn) in in vitro cultures of
dopaminergic neurons and microglia.
Finally, Christine Grienberger from Arthur Konnerth`s
lab in Munich introduced an in vivo study of cortical cir-
cuit dysfunction in the APP23/PS45 animal model of
Alzheimer`s Disease (AD). The group employed two-photon microscopy in order to image calcium responses
in the mouse primary visual cortex. Imaging data were
correlated with behavioral tests and analyses of plaque
densities as well as beta-amyloid load.
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